1.
Dr Absar Khalid Mir, Dr Mohammad Ahmad Abbasi, Dr Laiba Mustansar Sahi, et al. EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY. J Popl Ther Clin Pharmacol. 2024;31(6):1059-1065. doi:10.53555/jptcp.v31i6.6611